Locations
Alberta, Canada · Montréal, QC, Canada
industry
Health · Medical Devices
Size
11-50 employees
Stage
Seed
founded in
2020
Vi TAA Medical Solutions specializes in precision, personalized medicine for abdominal aortic aneurysms (AAA). Their proprietary RAW™ (Regional Areas of Weakness) Mapping technology analyzes aorta wall deformation using cardiac cycle images, integrating critical simulation data on blood flow and clot characteristics. Founded in 2019 by Dr. Elena Di Martino and Dr. Randy Moore, the company is currently undertaking clinical studies to validate its algorithms, aiming for regulatory approvals in Canada and the U.S. Vi TAA's innovative approach positions it as a leader in the field, addressing a critical need for effective AAA treatment.
Something looks off?